Cargando…
Access to Treatment for Hepatitis B Virus Infection — Worldwide, 2016
Autores principales: | Hutin, Yvan, Nasrullah, Muazzam, Easterbrook, Philippa, Nguimfack, Boniface Dongmo, Burrone, Esteban, Averhoff, Francisco, Bulterys, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054001/ https://www.ncbi.nlm.nih.gov/pubmed/30025413 http://dx.doi.org/10.15585/mmwr.mm6728a2 |
Ejemplares similares
-
Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis
por: Tan, Mingjuan, et al.
Publicado: (2020) -
The Role of Screening and Treatment in National Progress Toward Hepatitis C Elimination — Georgia, 2015–2016
por: Nasrullah, Muazzam, et al.
Publicado: (2017) -
Preventing hepatitis B virus infection: milestones and targets
por: Hutin, Yvan, et al.
Publicado: (2018) -
Progress Toward Hepatitis B and Hepatitis C Elimination Using a Catalytic Funding Model — Tashkent, Uzbekistan, December 6, 2019–March 15, 2020
por: Dunn, Rick, et al.
Publicado: (2020) -
The global hepatitis delta virus (HDV) epidemic: what gaps to address in order to mount a public health response?
por: Hayashi, Tomoyuki, et al.
Publicado: (2021)